Related references
Note: Only part of the references are listed.Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study
Kazuaki Shimamoto et al.
HYPERTENSION RESEARCH (2014)
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
Edmond C. K. Li et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011) - Digest Version
Hisao Ogawa
CIRCULATION JOURNAL (2013)
Epidemiology of Hypertension in Japan - Where Are We Now? -
Katsuyuki Miura et al.
CIRCULATION JOURNAL (2013)
Angiotensin receptor blockers for heart failure
Balraj S. Heran et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Inhibitory Effect of Valsartan Against Progression of Left Ventricular Dysfunction After Myocardial Infarction - T-VENTURE Study
Hiroshi Suzuki et al.
CIRCULATION JOURNAL (2009)
Characteristics and Outcomes of Hospitalized Patients With Heart Failure and Reduced vs Preserved Ejection Fraction - A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)
Miyuki Tsuchihashi-Makaya et al.
CIRCULATION JOURNAL (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2006)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure
A Matsumori
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
CB Granger et al.
LANCET (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study
P Jong et al.
LANCET (2003)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
K Dickstein et al.
LANCET (2002)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients
MD Flather et al.
LANCET (2000)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
CB Granger et al.
AMERICAN HEART JOURNAL (2000)
Share Paper
